Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of NK-1 receptor antogonists for treating substance use disorders

Use of NK-1 receptor antogonists for treating substance use disorders

US Patent 5919781 · Granted Jul 6, 1999

Estimated economic value: $132,808,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Urolithin derivatives and methods of use thereof2025
Pharmaceutical compounds2025
Structural support system for rockwork with mechanical fastening of adjacent chi2025
Isoquinoline compounds and uses thereof2025
Urolithin derivatives and methods of use thereof2025
Urolithin derivatives and methods of use thereof2025
ROR1-specific antigen binding molecules2025
Naphthyridine compounds and uses thereof2025
Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof2025
Therapeutic compounds2024
Azaindoles as inhibitors of HPK12024
Urolithin derivatives and methods of use thereof2023